(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 10.95% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Neuronetics's revenue in 2024 is $71,348,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2024 to be $2,348,942,824, with the lowest STIM revenue forecast at $2,341,801,371, and the highest STIM revenue forecast at $2,356,084,277. On average, 2 Wall Street analysts forecast STIM's revenue for 2025 to be $2,616,152,180, with the lowest STIM revenue forecast at $2,607,820,485, and the highest STIM revenue forecast at $2,624,483,875.
In 2026, STIM is forecast to generate $2,873,839,599 in revenue, with the lowest revenue forecast at $2,873,839,599 and the highest revenue forecast at $2,873,839,599.